The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Reinier M. van Hest

Department of Hospital Pharmacy

Erasmus Medical Center

Rotterdam

Netherlands

[email]@erasmusmc.nl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands. 2004 - 2007

References

  1. Time-dependent clearance of mycophenolic acid in renal transplant recipients. van Hest, R.M., van Gelder, T., Bouw, R., Goggin, T., Gordon, R., Mamelok, R.D., Mathot, R.A. Br. J. Clin. Pharmacol (2007) [Pubmed]
  2. Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients. van Hest, R.M., Doorduijn, J.K., de Winter, B.C., Cornelissen, J.J., Vulto, A.G., Oellerich, M., Löwenberg, B., Mathot, R.A., Armstrong, V.W., van Gelder, T. Ther. Drug. Monit (2007) [Pubmed]
  3. Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view. van Hest, R.M., Mathot, R.A., Vulto, A.G., Ijzermans, J.N., van Gelder, T. Ther. Drug. Monit (2006) [Pubmed]
  4. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. van Hest, R.M., Mathot, R.A., Pescovitz, M.D., Gordon, R., Mamelok, R.D., van Gelder, T. J. Am. Soc. Nephrol. (2006) [Pubmed]
  5. Individualization of mycophenolate mofetil dose in renal transplant recipients. van Hest, R.M., Hesselink, D.A., Vulto, A.G., Mathot, R.A., van Gelder, T. Expert. Opin. Pharmacother (2006) [Pubmed]
  6. Population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acid. van Hest, R.M. J. Postgrad. Med (2006) [Pubmed]
  7. Predicting the usefulness of therapeutic drug monitoring of mycophenolic acid: a computer simulation. van Hest, R., Mathot, R., Vulto, A., Weimar, W., van Gelder, T. Ther. Drug. Monit (2005) [Pubmed]
  8. Population pharmacokinetics of mycophenolic acid in renal transplant recipients. van Hest, R.M., van Gelder, T., Vulto, A.G., Mathot, R.A. Clin. Pharmacokinet (2005) [Pubmed]
  9. Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetics and application of a limited sampling strategy. van Hest, R.M., Mathôt, R.A., Vulto, A.G., Le Meur, Y., van Gelder, T. Ther. Drug. Monit (2004) [Pubmed]
 
WikiGenes - Universities